8 recruiting, 5 not yet recruiting, 4 unknown, 1 active not recruiting. 19 Phase 1, 10 Phase 2.
Follow Adebrelimab: new trials by email Literature Review of Adebrelimab trials Research Report on Adebrelimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer HRS-2329 Tablet, Nimotuzumab, HS-20093 - Pancreatic Cancer, RAS Mutations or Amplifications | Phase 1 / Phase 2 | Not yet recruiting | Zhejiang University | 80 | 2026-08-15 | 2026-08-31 |
| Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer Propranolol Hydrochloride, Adebrelimab, Chemotherapy - Small Cell Lung Cancer (SCLC) | Phase 1 | Recruiting | Second Xiangya Hospital of Central South University | 18 | 2026-05-29 | 2026-10-21 |
| Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer Adebrelimab, Gemcitabine + Cisplatin, Simvastatin 20mg - Advanced Biliary Tract Carcinoma | Phase 1 / Phase 2 | Recruiting | Tongji Hospital | 29 | 2026-01-30 | 2026-03-23 |
| A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer SHR-A2102, Adebrelimab, Cetuximab - Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 210 | 2025-07-11 | 2026-07-20 |
| A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors HS-10370, HS-20117, Adebrelimab - Advanced Solid Tumors, Colorectal Cancer | Phase 1 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 762 | 2025-05-30 | 2025-05-09 |
| ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. HS-20093, Anlotinib, Epirubicin - Osteosarcoma, Soft Tissue Sarcoma (STS) | Phase 1 | Not yet recruiting | Hansoh BioMedical R&D Company | 448 | 2024-12-20 | 2024-11-21 |
| A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors HS-10370, Adebrelimab, Cisplatin - Non-Small Cell Lung Cancer, Advanced Solid Tumors | Phase 1 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 350 | 2024-10-31 | 2024-09-19 |
| A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer Adebrelimab - Gastric Cancer | Phase 1 / Phase 2 | Recruiting | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | 52 | 2024-08-03 | 2025-01-15 |
| A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation HRS-4642, Adebrelimab, SHR-9839 - Advanced KRAS G12D Mutant Solid Tumors | Phase 1 / Phase 2 | Active not recruiting | Jiangsu HengRui Medicine Co., Ltd. | 47 | 2024-07-05 | 2025-09-19 |
| Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma HRS-4642, Adebrelimab, SHR-8068 - Pancreatic Cancer | Phase 1 / Phase 2 | Recruiting | Fudan University | 130 | 2024-06-17 | 2026-05-26 |
| Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors HRS2398, Adebrelimab - Advanced Solid Tumors | Phase 1 / Phase 2 | Unknown | Shanghai Hengrui Pharmaceutical Co., Ltd. | 88 | 2024-06-12 | 2024-07-05 |
| SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer SHR-8068, Adebrelimab, BP102 - Colorectal Cancer | Phase 1 / Phase 2 | Not yet recruiting | West China Hospital | 36 | 2024-05-01 | 2024-04-18 |
| ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors HS-20093, Adebrelimab, Cisplatin/ Carboplatin - Advanced Solid Tumor | Phase 1 | Recruiting | Hansoh BioMedical R&D Company | 610 | 2024-04-26 | 2024-07-18 |
| HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors HS-20089, Adebrelimab, Bevacizumab - Advanced Solid Tumors | Phase 1 | Recruiting | Hansoh BioMedical R&D Company | 1048 | 2024-04-11 | 2024-07-18 |
| Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas Adebrelimab, Dalpiciclib 100mg, Dalpiciclib 150mg - Esophageal Squamous Cell Carcinoma | Phase 1 | Unknown | West China Hospital | 6 | 2023-12-29 | 2024-03-06 |
| A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies Adebrelimab, Apatinib, Gemcitabine - Biliary Tract Malignancies | Phase 1 | Recruiting | First Affiliated Hospital of Fujian Medical University | 35 | 2023-12-23 | 2024-04-30 |
| A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors HRXG-K-1939, Adebrelimab - Advanced Solid Tumors | Phase 1 | Unknown | Fudan University | 30 | 2023-07-01 | 2023-07-12 |
| A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors Adebrelimab, SHR-1802, Carboplatin/Cisplatin - Advanced Solid Tumor | Phase 1 / Phase 2 | Completed | Shanghai Hengrui Pharmaceutical Co., Ltd. | 16 | 2023-04-28 | 2026-11-13 |
| Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma Adebrelimab, Bevacizumab, SHR-8068 - Advanced Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 129 | 2022-08-02 | 2024-06-21 |
Carcinoma, Non-Small-Cell Lung (2) · Colorectal Neoplasms (2) · Pancreatic Neoplasms (2) · Esophageal Squamous Cell Carcinoma (1) · Neoplasm Metastasis (1) · Osteosarcoma (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1)
Hansoh BioMedical R&D Company (3) · Fudan University (2) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (2) · Shanghai Hengrui Pharmaceutical Co., Ltd. (2) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (2) · West China Hospital (2) · Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center (1) · First Affiliated Hospital of Fujian Medical University (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Second Xiangya Hospital of Central South University (1) · Tongji Hospital (1) · Zhejiang University (1)
China (17)
Jin Zhou, MD.,PhD. (1) · Maolin Yan (1) · Wanguang Zhang, M.D. (1) · Yufeng Chen (1) · Zeyang Ding, M.D. (1)